Outlook Therapeutics Inc. (OTLK)
NASDAQ · Healthcare
Outlook Therapeutics Inc. Revenue 2015–2025
Outlook Therapeutics Inc. annual/quarterly revenue history and growth rate from 2015 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Outlook Therapeutics Inc. revenue for the quarter ending June 30, 2025 was 1.5 M, a 157.83% increase year-over-year.
- Outlook Therapeutics Inc. revenue for the twelve months ending June 30, 2025 was 3.8 M, a 45.02% increase year-over-year.
- Outlook Therapeutics Inc. annual revenue for 2025 was 1.4 M, a 82.65% decrease from 2019.
- Outlook Therapeutics Inc. annual revenue for 2019 was 8.1 M, a 163.84% increase from 2018.
- Outlook Therapeutics Inc. annual revenue for 2018 was 3.1 M, a 18.99% decrease from 2017.
- Outlook Therapeutics Inc. annual revenue for 2017 was 3.8 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Outlook Therapeutics Inc. Revenue — FAQ
Outlook Therapeutics Inc. (OTLK) revenue over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Outlook Therapeutics Inc.'s revenue?
Outlook Therapeutics Inc. (OTLK) reported revenue of $1M for fiscal 2025.
Where can I see OTLK's revenue history?
The chart and table above show Outlook Therapeutics Inc.'s revenue by year and by quarter, including the growth rate.